Acadia Healthcare Company, Inc. announced their participation in the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, where they will present their financial guidance for 2025, expecting revenues between $3.28 billion and $3.30 billion, adjusted EBITDA of $601 million to $611 million, and adjusted earnings per share of $1.94 to $2.04.